News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
564,336 Results
Type
Article (46376)
Company Profile (131)
Press Release (517829)
Multimedia
Podcasts (84)
Webinars (12)
Section
Business (156040)
Career Advice (2424)
Deals (29582)
Drug Delivery (120)
Drug Development (68938)
Employer Resources (152)
FDA (16122)
Job Trends (12469)
News (278386)
Policy (30385)
Tag
Academia (2377)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (87)
Alliances (39909)
ALS (92)
Alzheimer's disease (1456)
Antibody-drug conjugate (ADC) (142)
Approvals (16068)
Artificial intelligence (273)
Autoimmune disease (27)
Automation (13)
Bankruptcy (322)
Best Places to Work (9554)
BIOSECURE Act (22)
Biosimilars (115)
Biotechnology (79)
Bladder cancer (83)
Brain cancer (29)
Breast cancer (286)
Cancer (2235)
Cardiovascular disease (196)
Career advice (2029)
Career pathing (33)
CAR-T (147)
Cell therapy (423)
Cervical cancer (22)
Clinical research (56127)
Collaboration (771)
Company closure (2)
Compensation (559)
Complete response letters (29)
COVID-19 (2655)
CRISPR (45)
C-suite (238)
Cystic fibrosis (96)
Data (2140)
Decentralized trials (2)
Denatured (15)
Depression (54)
Diabetes (274)
Diagnostics (6608)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (42)
Drug discovery (105)
Drug pricing (126)
Drug shortages (30)
Duchenne muscular dystrophy (102)
Earnings (62673)
Editorial (47)
Employer branding (20)
Employer resources (137)
Events (82480)
Executive appointments (683)
FDA (17475)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (686)
Gene editing (108)
Generative AI (25)
Gene therapy (323)
GLP-1 (801)
Government (3973)
Grass and pollen (6)
Guidances (145)
Healthcare (15509)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (146)
Indications (27)
Infectious disease (2811)
Inflammatory bowel disease (137)
Inflation Reduction Act (9)
Influenza (54)
Intellectual property (93)
Interviews (451)
IPO (14416)
IRA (48)
Job creations (3289)
Job search strategy (1684)
Kidney cancer (11)
Labor market (37)
Layoffs (526)
Leadership (23)
Legal (7108)
Liver cancer (76)
Lung cancer (308)
Lymphoma (150)
Machine learning (9)
Management (52)
Manufacturing (321)
MASH (77)
Medical device (11833)
Medtech (11836)
Mergers & acquisitions (15708)
Metabolic disorders (748)
Multiple sclerosis (79)
NASH (22)
Neurodegenerative disease (107)
Neuropsychiatric disorders (33)
Neuroscience (2012)
NextGen: Class of 2025 (5171)
Non-profit (3345)
Now hiring (19)
Obesity (412)
Opinion (221)
Ovarian cancer (73)
Pain (93)
Pancreatic cancer (83)
Parkinson's disease (152)
Partnered (16)
Patents (238)
Patient recruitment (105)
Peanut (46)
People (45794)
Pharmaceutical (34)
Pharmacy benefit managers (22)
Phase I (16813)
Phase II (24314)
Phase III (19894)
Pipeline (1326)
Policy (176)
Postmarket research (2237)
Preclinical (6856)
Press Release (34)
Prostate cancer (108)
Psychedelics (35)
Radiopharmaceuticals (232)
Rare diseases (406)
Real estate (4591)
Recruiting (60)
Regulatory (21541)
Reports (32)
Research institute (2164)
Resumes & cover letters (403)
Rett syndrome (4)
RNA editing (3)
RSV (47)
Schizophrenia (78)
Series A (126)
Series B (83)
Service/supplier (9)
Sickle cell disease (55)
Special edition (18)
Spinal muscular atrophy (132)
Sponsored (33)
Startups (2937)
State (1)
Stomach cancer (16)
Supply chain (72)
Tariffs (54)
The Weekly (68)
Vaccines (781)
Venture capitalists (44)
Weight loss (295)
Women's health (33)
Worklife (20)
Date
Last 7 days (881)
Last 30 days (2813)
Last 365 days (30213)
2025 (11216)
2024 (32362)
2023 (36205)
2022 (46606)
2021 (50243)
2020 (47355)
2019 (37776)
2018 (28709)
2017 (29175)
2016 (27461)
2015 (30226)
2014 (23690)
2013 (19516)
2012 (20907)
2011 (21400)
2010 (19318)
Location
Africa (715)
Alabama (45)
Alaska (6)
Arizona (189)
Arkansas (10)
Asia (32774)
Australia (5723)
California (5880)
Canada (1651)
China (427)
Colorado (246)
Connecticut (277)
Delaware (143)
Europe (79785)
Florida (893)
Georgia (195)
Hawaii (1)
Idaho (39)
Illinois (471)
India (25)
Indiana (257)
Iowa (11)
Japan (157)
Kansas (88)
Kentucky (17)
Louisiana (8)
Maine (62)
Maryland (875)
Massachusetts (4393)
Michigan (190)
Minnesota (375)
Mississippi (1)
Missouri (72)
Montana (15)
Nebraska (24)
Nevada (59)
New Hampshire (59)
New Jersey (1660)
New Mexico (27)
New York (1662)
North Carolina (978)
North Dakota (8)
Northern California (2633)
Ohio (175)
Oklahoma (10)
Oregon (30)
Pennsylvania (1269)
Puerto Rico (9)
Rhode Island (24)
South America (1079)
South Carolina (23)
South Dakota (1)
Southern California (2216)
Tennessee (91)
Texas (839)
United States (21964)
Utah (189)
Virginia (140)
Washington D.C. (63)
Washington State (522)
West Virginia (3)
Wisconsin (61)
564,336 Results for "bioporto diagnostics a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioPorto A/S to host first quarter 2025 earnings webcast for investors
April 29, 2025
·
1 min read
Press Releases
BioPorto announces the Annual Report for 2024
March 20, 2025
·
6 min read
Press Releases
BioPorto A/S appoints new interim Chairman of the Board
January 30, 2025
·
4 min read
Press Releases
Correction: Private placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S
April 15, 2025
·
4 min read
Press Releases
BioPorto announces guidance for 2025 and aspirations for 2026 towards 2029
March 20, 2025
·
5 min read
Press Releases
BioPorto announces completion of an oversubscribed directed offering of 25 million new shares raising DKK 33.5 million
April 28, 2025
·
2 min read
Press Releases
BioPorto A/S announces Jens Due Olsen as a Board of Directors candidate intending to appoint Jens Due Olsen as Chair, along with updates on other candidates
March 5, 2025
·
5 min read
Press Releases
BioPorto A/S to Host Third Quarter 2024 Earnings Webcast
November 12, 2024
·
2 min read
Press Releases
BioPorto A/S Announces Changes to the US Commercial Organization
October 22, 2024
·
2 min read
Press Releases
BioPorto announces the publication of urinary NGAL reference ranges in healthy adult and pediatric individuals
January 23, 2025
·
3 min read
1 of 56,434
Next
